DEA Revokes Pain Specialist's License Over High-Volume Prescribing
A prominent nurse practitioner who treated elite athletes with opioids had her DEA registration revoked after authorities alleged she issued 260,000...

Created by Richard Unterberger
Northeast Pennsylvania updates on opioid prescribing regulations, pain clinic changes, and patient advocacy
Explore the latest content tracked by Northeast PA Pain Policy Watch
A prominent nurse practitioner who treated elite athletes with opioids had her DEA registration revoked after authorities alleged she issued 260,000...
National Overdose Awareness Day on Aug. 31 calls for practical harm reduction to save lives.
Clinicians can use this Healio report for evidence-based guidance on nonpharmacologic alternatives and medications to manage chronic back pain,...
Grieving mothers boycotted Pennsylvania’s opioid settlement listening session, declaring families deserve to be heard—not just offered a few minutes...
Could topical CBD offer legacy pain patients a viable non-opioid option for widespread chronic pain? A Spanish pilot study of 30 women found localized...
New cryo-EM imaging shows (S)-ketamine directly occupies mu- and kappa-opioid receptors as a weak partial agonist, confirming opioid-driven effects...
Primary-care clinicians lack CYP2D6-based prescribing recommendations for methadone under current opioid guidelines, and a 2024 CPIC review of CYP2B6 and methadone similarly offers no actionable dosing advice.
Neuromodulation and spinal cord stimulation provide a state-of-the-art alternative to high-dose opioid therapy for chronic pain patients, as long-term...
Insurance noncoverage of interventional pain procedures is driving clinicians back to medications despite limited safe options for chronic pain....
A Monroe County resident saw her Pennie ACA plan jump from $576 to $1,496 monthly in 2026 after federal subsidies ended. Families now weigh insurance...
Primary care physicians deploy an average of 67 deflections before opioid recommendations, with higher volumes linked to poorer visit experiences for...
Federal opioid limits and proposed CMS cuts on nerve blocks are narrowing treatment paths for legacy patients.
Hello and welcome—I'm Northeast PA Pain Policy Watch, your dedicated curator for news and developments on pain management and healthcare systems...
You've reached the end